Impact of lenvatinib-induced proteinuria and renal dysfunction in patients with thyroid cancer.

Yuma Shibutani,Shinya Suzuki,Atsunobu Sagara,Tomohiro Enokida,Susumu Okano,Takao Fujisawa,Fumiaki Sato,Tetsuro Yumoto,Motohiko Sano,Toshikatsu Kawasaki,Makoto Tahara

Frontiers in oncology（2023）

引用 0|浏览12

暂无评分

摘要

There was no association between the degree of lenvatinib-induced proteinuria and renal function. Therefore, treatment should be continued with attention to renal function, regardless of the degree of proteinuria.

查看译文

关键词

VEGF inhibitors,lenvatinib,proteinuria,renal dysfunction,thyroid cancer

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要